Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-23-006442
Filing Date
2023-04-21
Accepted
2023-04-21 16:30:29
Documents
15

Document Format Files

Seq Description Document Type Size
1 PRE 14A tgtx-20230421xpre14a.htm   iXBRL PRE 14A 898945
2 GRAPHIC tgtx-20230421xpre14a001.jpg GRAPHIC 7956
  Complete submission text file 0001558370-23-006442.txt   1571102

Data Files

Seq Description Document Type Size
3 EX-101.SCH tgtx-20230421.xsd EX-101.SCH 5867
4 EX-101.DEF tgtx-20230421_def.xml EX-101.DEF 7680
5 EX-101.LAB tgtx-20230421_lab.xml EX-101.LAB 14003
6 EX-101.PRE tgtx-20230421_pre.xml EX-101.PRE 6959
9 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20230421xpre14a_htm.xml XML 198318
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32639 | Film No.: 23836758
SIC: 2834 Pharmaceutical Preparations